Satoshi Hamauchi
Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun
Shimonagakubo, 4118777, Japan
Shimonagakubo, 4118777, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Journal: International journal of clinical oncology
Published: July 09, 2026
Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design).
Journal: Future oncology (London, England)
Published: April 15, 2026
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.
Journal: Japanese journal of clinical oncology
Published: February 20, 2026
Long-term follow-up of neoadjuvant chemotherapy in resectable human papillomavirus-associated oropharyngeal cancer.
Journal: International journal of clinical oncology
Published: January 13, 2026
Long-Term Administration of Multikinase Inhibitors Is a Potential Risk Factor for Atherosclerosis in Patients with Thyroid Cancer.
Journal: Cardiology
Published: July 25, 2025
Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Journal: International journal of clinical oncology
Published: March 19, 2025
Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 05, 2025
Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, noncomparative trial.
Journal: Gastrointestinal endoscopy
Published: January 24, 2025
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.
Journal: Investigational new drugs
Published: August 14, 2024
Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer.
Journal: Investigational new drugs
Published: April 18, 2024
Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.
Journal: The oncologist
Published: March 25, 2024
Last Updated: 09/26/2026